-
Product Insights
Progressive Multifocal Leukoencephalopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Progressive Multifocal Leukoencephalopathy - Drugs In Development, 2023’, provides an overview of the Progressive Multifocal Leukoencephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Progressive Multifocal Leukoencephalopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Polyomavirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Polyomavirus Infections - Drugs In Development, 2023’, provides an overview of the Polyomavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polyomavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Progressive Multifocal Leukoencephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by the JC polyomavirus. Its symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. The PML pipeline market research report provides comprehensive information on the therapeutics under development for PML, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...